NUVECTIS PHARMA INC. - COMMON STOCK

Nuvectis Pharma, Inc. Reports Fiscal Year 2021 Financial Results and Business Highlights

22 مارس 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Update - Nuvectis Pharma to Participate in a Fireside Chat at the 34th Annual Roth Conference

09 مارس 2022 09:12:44 بحسب Nasdaq GlobeNewswire

Nuvectis Announces Positive Data for NXP900 in Triple Negative Breast Cancer Preclinical Models with an Integrin-Linked Kinase (ILK) Loss

22 فبراير 2022 07:30:00 بحسب Nasdaq GlobeNewswire

Nuvectis Pharma Announces Closing of $16,000,000 Upsized Initial Public Offering of Common Stock

08 فبراير 2022 12:00:00 بحسب Nasdaq GlobeNewswire

Nuvectis Pharma, Inc. Announces Pricing of $16,000,000 Upsized Initial Public Offering of Common Stock

04 فبراير 2022 08:30:32 بحسب Nasdaq GlobeNewswire